In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated or positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with ...

Two abstracts on Clarity’s diagnostic COBRA and CLARIFY trials with 64Cu-SAR-bisPSMA have been accepted for presentation at the American Society of Clinical Oncology Genitourinary Cancers Symposium ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

WVU Medicine St. Joseph’s Hospital is proud to announce the addition of two cutting-edge imaging services: PET/CT and ...

Obstructive uropathy secondary to malignant ureteral strictures is rare, with carcinoma of the breast accounting for less ...

As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

An imaging test helps health care providers better understand what may be wrong with you so they can make treatment decisions or rule out certain health problems. There are many different types of ...

A Prospective Single-Center Study Diagnostic Efficacy of Various Imaging Modalities Across Different Stages of Prostate Cancer: A Network Meta-Analysis of Diagnostic Studies Clinical Factors That ...

On this important global occasion, World Cancer Awareness Day, awareness continues to be raised about cancer—a disease that ...

Jammu Government Medical College GMC took a significant step in cancer management by unveiling the Cancer Policy for Jammu and Kashmir UT on Tuesday ...

Advances in AI are significantly reshaping cancer treatment by enhancing various aspects of diagnosis, treatment planning and ...